rs2255336
|
|
Lupus Erythematosus, Systemic
|
|
0.020 |
GeneticVariation
|
BEFREE |
Prevalence of the NKG2D Thr72Ala polymorphism in patients with systemic lupus erythematosus.
|
21598106 |
2012 |
rs2255336
|
|
Lupus Erythematosus, Systemic
|
|
0.020 |
GeneticVariation
|
BEFREE |
In conclusion, based on our study results, SLE is associated with the SNP rs2255336 of NKG2D.
|
19735685 |
2010 |
rs11053781
|
|
Congenital contractural arachnodactyly
|
|
0.010 |
GeneticVariation
|
BEFREE |
Two of the NKG2D SNPs were associated with an increased risk of CCA: rs11053781 [odds ratio (OR) = 2.08, 95% confidence interval (CI) = 1.31-3.29, corrected P (P(c)) = 0.011] and rs2617167 (OR = 2.32, 95% CI = 1.47-3.66, P(c) = 0.0020).
|
18023027 |
2008 |
rs2255336
|
|
Congenital cytomegalovirus infection
|
|
0.010 |
GeneticVariation
|
BEFREE |
A Thr72Ala polymorphism in the NKG2D gene is associated with early symptomatic congenital cytomegalovirus disease.
|
25861030 |
2015 |
rs2255336
|
|
cervical cancer
|
|
0.010 |
GeneticVariation
|
BEFREE |
Using polymerase chain reaction-restriction fragment length polymorphisms, we examined the NKG2D Thr72Ala polymorphism in patients with cervical cancer (n=353) and controls (n=366) in a Polish population.
|
22480139 |
2012 |
rs2255336
|
|
Cervix carcinoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
Using polymerase chain reaction-restriction fragment length polymorphisms, we examined the NKG2D Thr72Ala polymorphism in patients with cervical cancer (n=353) and controls (n=366) in a Polish population.
|
22480139 |
2012 |
rs2255336
|
|
Malignant tumor of cervix
|
|
0.010 |
GeneticVariation
|
BEFREE |
Using polymerase chain reaction-restriction fragment length polymorphisms, we examined the NKG2D Thr72Ala polymorphism in patients with cervical cancer (n=353) and controls (n=366) in a Polish population.
|
22480139 |
2012 |
rs2617160
|
|
Hepatitis B, Chronic
|
|
0.010 |
GeneticVariation
|
BEFREE |
Single marker association analysis was conducted and the SNP rs2617160 with a TT genotype in NKG2D was associated significantly with an increased risk of chronic hepatitis B (P = 0.044; OR = 1.49; 95% CI = 1.01-2.19).
|
20648603 |
2010 |